Optimising Paediatric HIV Treatment: Recent Developments and Future Directions
Pediatric Drugs · 2024-11 · 26 (6) · 631-648
DOI: 10.1007/s40272-024-00656-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Drugs, online erschienen am 22.10.2024. Verfasst von Anne E M Kamphuis und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands. Anne.Kamphuis@radbou…. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
Treatment options for children living with HIV have historically been less effective, less practical and more difficult to implement compared with those for adults, as the research and development of new drugs for children has lagged behind. Significant progress has been achieved in response to the paediatric HIV epidemic over the last decade. Several optimised paediatric antiretroviral formulations are currently available or in development, including fixed-dose combination tablets containing a complete World Health Organization-recommended regimen. Despite these advancements, virological suppression rates in children are generally lower than in adults. Even when oral fixed-dose combinations with the optimal target profiles are developed, for some children virological suppression is not achievable for reasons such as adherence challenges, intolerance, toxicity and genotypic resistance. New safe, effective, well-tolerated antiretroviral agents from existing and novel classes, as well as innovative administration strategies are essential. To achieve the UNAIDS target of virological suppression in 95% of children receiving antiretroviral therapy, concerted efforts are required. This includes identifying priority drugs in line with latest developments, focusing drug development studies on these priorities, ensuring a timely technical knowledge transfer between originator and generic companies, accelerating regulatory approvals and facilitating procurement and implementation in countries. Success in these efforts depends on collaboration among all stakeholders, including communities, researchers, pharmaceutical companies, guideline and policymakers, governments, funders, regulators and healthcare providers. This review outlines which paediatric antiretroviral therapies are currently available, those which are under development and the future directions of paediatric HIV treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands. Anne.Kamphuis@radboudumc.nl.
- Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
- Medical Research Council Clinical Trials Unit at University College London, Institute of Clinical Trials and Methodology, London, UK.
- Fundación de Investigación Biomédica Hospital 12 de Octubre, Instituto de Investigación 12 de Octubre (imas12), Madrid, Spain.
- Department of Pediatrics, Infanta Sofía University Hospital, Fundación para la Investigación Biomédica e Innovación, Hospital Universitario Infanta Sofía y Hospital del Henares (FIIB HUIS HHEN), Madrid, Spain.
- Universidad Europea de Madrid, Madrid, Spain.
Förderung
- NIAID NIH HHS
Zitieren
APA
Kamphuis, A. E. M., Bamford, A., Tagarro, A., Cressey, T. R., Bekker, A., Amuge, P., Mujuru, H. A., Ndongo, F. A., Diack, A., Compagnucci, A., Lallemant, M., Colbers, A., & Turkova, A. (2024). Optimising Paediatric HIV Treatment: Recent Developments and Future Directions. Pediatric Drugs, 26(6), 631-648. https://doi.org/10.1007/s40272-024-00656-4
Vancouver
Kamphuis AEM, Bamford A, Tagarro A, Cressey TR, Bekker A, Amuge P, et al. Optimising Paediatric HIV Treatment: Recent Developments and Future Directions. Pediatric Drugs. 2024;26(6):631-648. doi:10.1007/s40272-024-00656-4
BibTeX
@article{Kamphuis2024,
author = {Kamphuis, Anne E M and Bamford, Alasdair and Tagarro, Alfredo and Cressey, Tim R and Bekker, Adrie and Amuge, Pauline and Mujuru, Hilda Angela and Ndongo, Francis Ateba and Diack, Aminata and Compagnucci, Alexandra and Lallemant, Marc and Colbers, Angela and Turkova, Anna},
title = {Optimising Paediatric HIV Treatment: Recent Developments and Future Directions},
journal = {Pediatric Drugs},
year = {2024},
volume = {26},
number = {6},
pages = {631--648},
doi = {10.1007/s40272-024-00656-4}
}
EUVIMED